Smith & Nephew posts 3% rise in FY sales, sees no Brexit impact

Writer, Stock Market Wire
Thursday, February 7, 2019 - 08:29

British medical equipment manufacturer Smith & Nephew posted a small increase in revenue in its full-year results on Thursday as it said it did not anticipate any significant impact on its business from Brexit.

Full-year revenue rose 3% year on year to $4904m while fourth-quarter revenue was just 1% above prior-year levels at $1294m.

Its trading profit rose to $1123m from $1048m a year earlier while the trading profit margin rose to 22.9% from 22% in 2017.

The company said it did not believe that the UK's decision to leave the EU would have a significant impact on its long-term ability to conduct business into and out of the EU or UK. The UK accounts for approximately 5% of the firm's global revenue and the majority of its manufacturing takes place outside the UK and EU. Nonetheless, the company said it was making good progress with preparations for the various scenarios.

Looking forward, the company said it expected underlying revenue to increase 2.5-3.5% with an expected trading profit margin in the 22.8-23.2% range.

The company would pay a final dividend of $0.22/share, which, together with an interim dividend of $0.14/share, would give a total full-year distribution of $0.36, a year-on-year increase of 3%.

Smith & Nephew also announced five new strategic imperatives, which would form its value-creation plan for the medium term and build on its previously announced new global commercial model.

At 8:29am: (LON:SN.) Smith Nephew PLC share price was +34.75p at 1496.25p


Related content

Just Eat hit by slowing growth, and Smith & Nephew becomes latest FTSE 100 firm to see CEO depart

“The FTSE 100 trades higher on Monday morning despite the so-called ‘Super Saturday’ sitting of the House of Commons failing to provide the certainty on...

Mon, 21/10/2019 - 09:36


Smith & Nephew CEO Namal Nawana to stand down

Medical equipment manufacturer Smith & Nephew said that chief executive Namal Nawana was standing down at the end of October to 'pursue other opportunities outside...

Mon, 21/10/2019 - 07:14


Broker Forecast - UBS issues a broker note on Smith & Nephew PLC

UBS today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1830p (from 1730p).

Broker Forecasts data...

Tue, 06/08/2019 - 12:20


Broker Forecast - Berenberg issues a broker note on Smith & Nephew PLC

Berenberg today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 2265p (from 2210p).

Broker Forecasts data...

Mon, 05/08/2019 - 08:20


Royal Bank of Scotland’s financial targets out of reach, and Pets at Home is wagging its tail again

“What an ugly start to August for global markets. Trump’s latest tariffs on China have put equities into freefall with stock prices marked down sharply,”...

Fri, 02/08/2019 - 09:42